Search for: "Tom Lamb"
Results 21 - 40
of 1,039
Sorted by Relevance
|
Sort by Date
31 Mar 2009, 12:16 pm
Digitek Brand Of Generic Digoxin Tablets Had Been Recalled In April 2008 For Same Reason (Posted by Tom Lamb at DrugInjuryWatch.com) On March 31, 2009 the FDA announced another generic digoxin pill recall by posting this company press release on the agency's web site: "Caraco Pharmaceutical Laboratories, Ltd. [read post]
27 Aug 2008, 2:20 pm
This Petition Is Sponsored By A Group Of Concerned Citizens Called "Americans for Drug and Device Accountability" (Posted by Tom Lamb at DrugInjuryWatch.com) In several earlier posts I have advocated that any application of the federal preemption doctrine to drug injury lawsuits would effectively eliminate a significant incentive for the drug company to ensure that its drug labels reflect accurate and up-to-date safety information, i.e., the possibility of… [read post]
2 Jan 2007, 1:51 pm
January 2007 Article Sets Forth Reports Made To Health Canada In Past Ten Years (Posted by Tom Lamb at DrugInjuryWatch.com) The January 2, 2007 edition of the Canadian Adverse Reaction Newsletter (Volume 17, Issue 1) includes an article concerning reports of blood sugar problems and liver disorders associated with Levaquin (levofloxacin) made to Health Canada during the past ten years According to this article, entitled "Levofloxacin: dysglycemia and liver disorders": … [read post]
15 Aug 2007, 2:41 pm
Researchers Find There Is No Such Risk, However, For Men Using This Atrial Fibrillation Heart Drug (Posted by Tom Lamb at DrugInjuryWatch.com) An August 14, 2007 article published by Reuters, "Heart drug may lead to pacemaker use in women", reports a rather peculiar finding concerning the Wyeth (WYE) heart drug Cordarone (amiodarone), used to treat atrial fibrillation, insofar that a serious side effect of this drug appears to affect only women and not men. [read post]
15 Nov 2010, 2:12 pm
November 2010 FDA Approval Of Merck Action Raises Profile Of This Emerging Drug Safety Issue (Posted by Tom Lamb at DrugInjuryWatch.com) As we reported recently, the October 2010 issue of the Canadian Adverse Reaction Newsletter (CARN) included an article titled "Statins and interstitial lung disease". [read post]
9 Oct 2007, 2:50 pm
Meridia Can Increase Blood Pressure And Heart Rate Leading To Possible Serious Cardiovascular Problems (Posted by Tom Lamb at DrugInjuryWatch.com) The Canadian Adverse Reaction Newsletter (CARN) released in October 2007 (Volume 17, Issue 4) includes an article about the anti-obesity drug Meridia (sibutramine), "Contraindicated use of sibutramine and cardiovascular adverse reactions". [read post]
9 Dec 2009, 8:14 pm
Lieutenant-General Sir Graham Lamb, a man who does not mince words as can [...] [read post]
30 Mar 2009, 1:35 pm
This Event In Support Of Proposed Medical Device Safety Act Is Organized By The "Campaign to Stop Corporate Immunity" Group (Posted by Tom Lamb at DrugInjuryWatch.com) The Campaign to Stop Corporate Immunity (CSCI) group has arranged for some patients injured by defective medical devices -- such as the recalled Medtronic Sprint Fidelis lead wires that were used in certain defibrillators -- to be in Washington, DC on Tuesday, March 31, 2009 for the purpose of… [read post]
26 Mar 2007, 2:53 pm
The Letter Concerns Black-Box Warning, Prescribing Changes, And Patient Medication Guide Announced Back In Mid-February 2007 (Posted by Tom Lamb at DrugInjuryWatch.com) On March 26, 2007 the FDA announced that a so-called "Dear Doctor" letter regarding the antibiotic Ketek (telithromycin) has been sent by Sanofi-Aventis to healthcare professionals alerting them to new safety information for Ketek. [read post]
5 Mar 2012, 1:05 pm
Prescriber Error, Impaired Renal Function, Patient Age, And Lack Of An Effective Reversal Agent Are Cited (Posted by Tom Lamb at DrugInjuryWatch.com) A Letter to The Editor, titled "Bleeding Risk with Dabigatran in the Frail Elderly" (subscription required), which appeared in the March 1, 2012 edition of the New England Journal of Medicine (NEJM) may help explain when and why there is a serious bleeding risk associated with Pradaxa (dabigatran). [read post]
15 Feb 2008, 2:30 pm
Action Reportedly Intended To Emphasize 2007 Label Change About Severe, Possibly Fatal Liver And Skin Side Effects (Posted by Tom Lamb at DrugInjuryWatch.com) A February 14, 2008 Reuters article, "Bayer warns doctors on rare Avelox side effects", reports that this German drug company is sending warning letters to doctors in Europe about the antibiotic Avelox, one of its top-selling drugs. [read post]
26 Sep 2012, 10:20 am
Use Of Pradaxa After ACS Is Associated With Increased Rate Of Major Bleeding, And Concomitant Use Of Pradaxa With Multaq Is Contraindicated (Posted by Tom Lamb at DrugInjuryWatch.com) When Pradaxa (dabigatran) is used to prevent thrombotic events after an acute coronary syndrome (ACS), it is associated with increased rates of major bleeding that offsets any antithrombotic benefit, according to a September 24, 2012 (Online First) Archives of Internal Medicine article, "Use… [read post]
29 Sep 2009, 10:06 am
(Posted by Tom Lamb at DrugInjuryWatch.com) On September 25, 2009 the FDA posted on its web site "Information for Healthcare Professionals - Acute pancreatitis and sitagliptin (marketed as Januvia and Janumet)". [read post]
30 May 2012, 1:37 pm
Researchers Find Increased Number Of Low-Energy Subtrochanteric Fractures For A Period Ten Years After Introduction Of Fosamax In That Country (Posted by Tom Lamb at DrugInjuryWatch.com) At the Orthopaedic Proceedings section of the Journal of Bone & Joint Surgery, British Volume, web site there is an item that presents some findings from a recent Australian study which supports the apparent link between Fosamax and atypical femur fractures. [read post]
12 Feb 2007, 11:12 am
New Package Insert, Or Label, For Ketek Will Get Black-box Warning And Medication Guide For Patients, Also (Posted by Tom Lamb at DrugInjuryWatch.com) In mid-December 2006 an FDA advisory panel recommended that any future use of the antibiotic Ketek should be restricted. [read post]
12 Oct 2009, 2:07 pm
Is Pancreatitis A Januvia Side Effect Or Is There An Increased Risk Of This Medical Condition Among Type 2 Diabetics Across All Treatments (Posted by Tom Lamb at DrugInjuryWatch.com) A few weeks back we reported that the FDA wants Merck to change the package insert, or label, for the diabetes drug Januvia (sitagliptin) so as to show an increased warning about the risk of developing pancreatitis. [read post]
28 Sep 2011, 1:43 pm
Possibly Increased Risk Of Blood Clot-Related Side Effects Like PE And DVT Suggested By Postmarketing Studies (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: Ortho Evra Update: October 2011 FDA Study Finds Increased Risk Of Serious Blood Clot Side Effects Like Pulmonary Embolism (PE) And Deep Vein Thrombosis (DVT) (11/2/11) _____________________________________________________________________ On… [read post]
30 Jul 2007, 12:11 am
Read Selected Essays From 77 Diverse Legal Blogs (aka Blawgs) In This Free eBook From TechnoLawyer (Posted by Tom Lamb at DrugInjuryWatch.com) On July 30, 2007 TechnoLawyer issued a press release announcing the launch of BlawgWorld 2007, a free eBook that features a diverse and impressive collection of essays from the so-called legal blogosphere. [read post]
30 May 2012, 1:37 pm
Researchers Find Increased Number Of Low-Energy Subtrochanteric Fractures For A Period Ten Years After Introduction Of Fosamax In That Country (Posted by Tom Lamb at DrugInjuryWatch.com) At the Orthopaedic Proceedings section of the Journal of Bone & Joint Surgery, British Volume, web site there is an item that presents some findings from a recent Australian study which supports the apparent link between Fosamax and atypical femur fractures. [read post]
24 Aug 2009, 1:30 pm
FDA Early Communication Makes Clear That No Definite Association Between Liver Injury And Orlistat Has Been Established At This Time (Posted by Tom Lamb at DrugInjuryWatch.com) On May 22, 2009 we first reported that the FDA is investigating the obesity drugs Xenical and Alli for a possible link with liver damage. [read post]
